The Ikaros gene, which encodes a family of hemopoietic-specific zinc f
inger proteins, is described as a central regulator of lymphocyte diff
erentiation. During fetal development, it is required at the earliest
stage of T cell and B cell specification. In the adult, however, lymph
oid lineages rely on Ikaros at distinct phases of their development. I
ts activity is essential for the generation of B cell but not of T cel
l precursors, although the differentiation of the latter is not normal
. A significant increase in CD4 thymocytes and their immediate precurs
ors is detected, and because these cells lack markers that correlate w
ith positive selection, a deregulation in their maturation process is
suggested. Furthermore, Ikaros-null thymocytes hyperproliferate in res
ponse to T cell receptor (TCR) signaling; within days after their appe
arance in the thymus, clonally expanding populations are detected. Der
egulated TCR-mediated responses and the fast kinetics of tumor develop
ment in these mutant thymocytes implicate Ikaros as a central tumor su
ppressor gene for the T cell lineage. In addition, lack of natural kil
ler cells and selective defects in gamma delta T cells and dendritic a
ntigen-presenting cells point to Ikaros as an essential factor for the
establishment of early branchpoints of the T cell pathway. The domina
nt interference activity of Ikaros isoforms unable to bind DNA and the
ir effects in lymphocyte development suggest that Ikaros works in conc
ert with other factors. The role of Aiolos, a lymphoid-restricted and
structurally related gene, in lymphoid differentiation is discussed. A
model is proposed that defines Ikaros as the backbone of a complex re
gulatory protein network that controls cell fate decisions and regulat
es homeostasis in the hemo-lymphoid system. Changes in this regulatory
network may reflect differentiation and proliferation adjustments mad
e in hemo-lymphoid progenitors and precursors as they give rise to the
cells of our immune system.